Velocity Clinical Research, Valparaiso

Clinical research site in Valparaiso, Indiana

Part of Velocity Clinical Research

As of July 2026, 3 paid clinical trials are recruiting at Velocity Clinical Research, Valparaiso in Valparaiso, Indiana. Active studies at this site cover conditions such as Atherosclerotic Cardiovascular Disease, Chronic Obstructive Pulmonary Disease and Obesity. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Velocity Clinical Research, Valparaiso (3)

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

for Atherosclerotic Cardiovascular Disease

138 locations incl. Daphne

Sponsor: Amgen

Sex: All·Age: 45 - 99

Code: NCT07037433·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD

for Chronic Obstructive Pulmonary Disease

54 locations incl. Dothan

Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Sex: All·Age: 40 - 80

Code: NCT07016412·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

for Rhinovirus Infection

14 locations incl. Tempe

Sponsor: Altesa Biosciences, Inc.

Sex: All·Age: 40 - 85

Code: NCT07610395·Phase 2·Recruiting·Listed May 28, 2026

Apply to this trial

More research sites in Valparaiso

Northwest Cancer Center - Valparaiso (27 trials)
Velocity Clinical Research - Valparaiso (3 trials)
Clinical Trial Site (1 trial)
Interventional Pain Mgmt (1 trial)

Explore more

Paid clinical trials in Valparaiso, IN · Indiana clinical trials